1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow KRAS Mutated Colorectal Cancer: new trials by email Literature Review of KRAS Mutated Colorectal Cancer trials Research Report on KRAS Mutated Colorectal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases Modified FOLFOX6, Aflibercept, Surgery - Colorectal Cancer Metastatic, Liver Metastases | Phase 2 / Phase 3 | Withdrawn | European Organisation for Research and Treatment of Cancer - EORTC | 2012-12-01 | 2017-05-09 |
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1) · Surgical Procedures, Operative (1) · aflibercept (1)
European Organisation for Research and Treatment of Cancer - EORTC (1)